Pliant Therapeutics Inc (PLRX)
11.88
-0.02
(-0.17%)
USD |
NASDAQ |
Apr 25, 16:00
11.89
+0.01
(+0.08%)
After-Hours: 20:00
Pliant Therapeutics Cash from Operations (Quarterly): -25.10M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -25.10M |
| September 30, 2023 | -36.22M |
| June 30, 2023 | -24.76M |
| March 31, 2023 | -30.28M |
| December 31, 2022 | -31.24M |
| September 30, 2022 | -18.50M |
| June 30, 2022 | -24.40M |
| March 31, 2022 | -20.50M |
| December 31, 2021 | -19.86M |
| September 30, 2021 | -22.51M |
| Date | Value |
|---|---|
| June 30, 2021 | -19.40M |
| March 31, 2021 | -13.66M |
| December 31, 2020 | -16.48M |
| September 30, 2020 | -15.79M |
| June 30, 2020 | 7.772M |
| March 31, 2020 | -12.77M |
| December 31, 2019 | 36.74M |
| September 30, 2019 | -14.88M |
| June 30, 2019 | -13.77M |
| March 31, 2019 | -10.85M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-36.22M
Minimum
Sep 2023
36.74M
Maximum
Dec 2019
-16.61M
Average
-19.40M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Masimo Corp | 77.10M |
| Liquidia Corp | -15.98M |
| Vor Biopharma Inc | -24.03M |
| CEL-SCI Corp | -4.888M |
| AIM ImmunoTech Inc | -9.758M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 31.92M |
| Cash from Financing (Quarterly) | 0.219M |
| Free Cash Flow | -117.28M |
| Free Cash Flow Per Share (Quarterly) | -0.42 |
| Free Cash Flow Yield | -16.82% |